Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PREVALENCE, Characteristics, and Awareness of Chronic Kidney Disease in Croatia: The EH-UH 2 Study.
Jelaković A, Radunović D, Josipović J, Željković Vrkić T, Gellineo L, Domislović M, Prelević V, Živko M, Fuček M, Marinović Glavić M, Bašić-Jukić N, Pećin I, Bubaš M, Capak K, Jelaković B. Jelaković A, et al. Among authors: gellineo l. J Clin Med. 2024 Nov 13;13(22):6827. doi: 10.3390/jcm13226827. J Clin Med. 2024. PMID: 39597972 Free PMC article.
Assessment of Salt, Potassium, and Iodine Intake in the Croatian Adult Population Using 24 h Urinary Collection: The EH-UH 2 Study.
Marinović Glavić M, Bilajac L, Bolješić M, Bubaš M, Capak K, Domislović M, Džakula A, Fuček M, Gellineo L, Jelaković A, Josipović J, Jukić T, Juraga D, Pećin I, Prelević V, Radunović D, Reiner Ž, Rukavina T, Šušnjara P, Vasiljev V, Vidranski V, Jelaković B. Marinović Glavić M, et al. Among authors: gellineo l. Nutrients. 2024 Aug 7;16(16):2599. doi: 10.3390/nu16162599. Nutrients. 2024. PMID: 39203736 Free PMC article.
Renal Denervation in the Treatment of Resistant Hypertension and Difficult-to-Control Hypertension - Consensus Document of the Croatian Hypertension League - Croatian Society of Hypertension, Croatian Cardiac Society, Croatian Endovascular Initiative, Croatian Society for Diabetes and Metabolic Diseases, Croatian Renal Association, and Croatian Society of Family Physicians of the Croatian Medical Association.
Jelaković B, Perkov D, Barišić K, Bukal N, Gellineo L, Jelaković A, Josipović J, Prkačin I, Željković Vrkić T, Živko M; On the behalf of Task force for the Resistant Hypertension and Renal Denervation of the Croatian Hypertension League. Jelaković B, et al. Among authors: gellineo l. Vasc Health Risk Manag. 2023 Dec 11;19:805-826. doi: 10.2147/VHRM.S422773. eCollection 2023. Vasc Health Risk Manag. 2023. PMID: 38108022 Free PMC article.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Trends, Characteristic, and Outcomes of Preterm Infants Who Received Postnatal Corticosteroid: A Cohort Study from 7 High-Income Countries.
Parikh S, Reichman B, Kusuda S, Adams M, Lehtonen L, Vento M, Norman M, San Feliciano L, Isayama T, Hakansson S, Helenius K, Bassler D, Yang J, Shah PS, Gellineo L; International Network for Evaluation of Outcomes (iNeo) of neonates investigators. Parikh S, et al. Among authors: gellineo l. Neonatology. 2023;120(4):517-526. doi: 10.1159/000530128. Epub 2023 Apr 25. Neonatology. 2023. PMID: 37166345 Free PMC article.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Treatment of Hypertension Induced Albuminuria.
Knežević T, Gellineo L, Jelaković A, Premužić V, Dika Ž, Laganović M, Jelaković B. Knežević T, et al. Among authors: gellineo l. Curr Pharm Des. 2018;24(37):4404-4412. doi: 10.2174/1381612825666181126170354. Curr Pharm Des. 2018. PMID: 30479206
Melanomas in Renal Transplant Recipients: A Single-center Study.
Borlinić T, Knežević T, Gellineo L, Franceschi M, Bukvić Mokos Z, Bašić-Jukić N. Borlinić T, et al. Among authors: gellineo l. Acta Dermatovenerol Croat. 2017 Dec;25(4):281-284. Acta Dermatovenerol Croat. 2017. PMID: 30064600
11 results